The estimated GFR, but not the stage of diabetic nephropathy graded by the urinary albumin excretion, is associated with the carotid intima-media thickness in patients with type 2 diabetes mellitus: a cross-sectional study.
BACKGROUND
To study the relationship between the intima-media thickness (IMT) of the carotid artery and the stage of chronic kidney disease (CKD) based on the estimated glomerular filtration rate (eGFR) and diabetic nephropathy graded by the urinary albumin excretion (UAE) in the patients with type 2 diabetes mellitus.


METHODS
A cross-sectional study was performed in 338 patients with type 2 diabetes mellitus. The carotid IMT was measured using an ultrasonographic examination.


RESULTS
The mean carotid IMT was 1.06 +/- 0.27 mm, and 42% of the subjects showed IMT thickening (>or= 1.1 mm). Cerebrovascular disease and coronary heart disease were frequent in the patients with IMT thickening. The carotid IMT elevated significantly with the stage progression of CKD (0.87 +/- 0.19 mm in stage 1, 1.02 +/- 0.26 mm in stage 2, 1.11 +/- 0.26 mm in stage 3, and 1.11 +/- 0.27 mm in stage 4+5). However, the IMT was not significantly different among the various stages of diabetic nephropathy. The IMT was significantly greater in the diabetic patients with hypertension compared to those without hypertension. The IMT positively correlated with the age, the duration of diabetes mellitus, and the brachial-ankle pulse wave velocities (baPWV), and negatively correlated with the eGFR. In a stepwise multivariate regression analysis, the eGFR and the baPWV were independently associated with the carotid IMT.


CONCLUSIONS
Our study is the first report showing a relationship between the carotid IMT and the renal parameters including eGFR and the stages of diabetic nephropathy with a confirmed association between the IMT and diabetic macroangiopathy. Our study further confirms the importance of intensive examinations for the early detection of atherosclerosis and positive treatments for hypertension, dyslipidaemia, obesity, as well as hyperglycaemia are necessary when a reduced eGFR is found in diabetic patients.
Ito
Hiroyuki
H
Department of Diabetes, Metabolism and Kidney Disease, Edogawa Hospital, Tokyo, Japan. ito@edogawa.or.jp
Komatsu
Yuko
Y
Mifune
Mizuo
M
Antoku
Shinichi
S
Ishida
Hidenori
H
Takeuchi
Yuichiro
Y
Togane
Michiko
M
D000368:Aged; D000419:Albuminuria / Q000000981:diagnostic imaging / Q000209:etiology* / Q000503:physiopathology; D002339:Carotid Arteries / Q000000981:diagnostic imaging*; D002340:Carotid Artery Diseases / Q000000981:diagnostic imaging / Q000209:etiology* / Q000503:physiopathology; D016022:Case-Control Studies; D002561:Cerebrovascular Disorders / Q000000981:diagnostic imaging / Q000209:etiology / Q000503:physiopathology; D003327:Coronary Disease / Q000000981:diagnostic imaging / Q000209:etiology / Q000503:physiopathology; D003430:Cross-Sectional Studies; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000000981:diagnostic imaging / Q000503:physiopathology; D003925:Diabetic Angiopathies / Q000000981:diagnostic imaging / Q000209:etiology* / Q000503:physiopathology; D003928:Diabetic Nephropathies / Q000000981:diagnostic imaging / Q000209:etiology* / Q000503:physiopathology; D018450:Disease Progression; D005260:Female; D005919:Glomerular Filtration Rate; D006801:Humans; D006973:Hypertension / Q000000981:diagnostic imaging / Q000209:etiology / Q000503:physiopathology; D007668:Kidney / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D012720:Severity of Illness Index; D017539:Tunica Intima / Q000000981:diagnostic imaging*; D017540:Tunica Media / Q000000981:diagnostic imaging*; D014463:Ultrasonography
Hypertension. 2005 Jul;46(1):38-43
15956113
Diabetes Res Clin Pract. 2009 Jan;83(1):50-3
19070383
Diabet Med. 2007 Dec;24(12):1329-35
17941863
Hypertens Res. 2008 May;31(5):841-50
18712038
Kidney Int. 2004 Jul;66(1):448-54
15200455
Intern Med. 2008;47(5):391-8
18310969
Circulation. 2002 Oct 15;106(16):2085-90
12379578
Hypertens Res. 2003 Oct;26(10):801-6
14621183
J Hypertens. 2008 Apr;26(4):791-7
18327090
Diabet Med. 2005 Nov;22(11):1558-65
16241922
Eur Heart J. 2005 Feb;26(3):279-87
15618058
Am J Kidney Dis. 2005 Nov;46(5):856-62
16253725
J Nephrol. 2007 Mar-Apr;20(2):204-11
17514625
Circulation. 2000 Sep 26;102(13):1503-10
11004140
Circulation. 2003 Oct 28;108(17):2154-69
14581387
JAMA. 2010 Feb 3;303(5):423-9
20124537
JAMA. 2001 Jul 25;286(4):421-6
11466120
N Engl J Med. 2005 Dec 22;353(25):2643-53
16371630
Am J Kidney Dis. 2003 Jan;41(1):1-12
12500213
Stroke. 1997 Sep;28(9):1710-6
9303013
Kidney Int. 2005 Jun;67(6):2089-100
15882252
Diabet Med. 2007 Dec;24(12):1482-6
17971183
Diabetes Care. 1999 Nov;22(11):1851-7
10546019
J Am Soc Nephrol. 2009 Aug;20(8):1813-21
19443635
J Am Soc Nephrol. 2005 Jul;16(7):2156-61
15872076
Am J Kidney Dis. 2004 Jan;43(1):45-52
14712426
Diabetes Care. 1999 Feb;22(2):333-8
10333954
Diabetes Care. 1992 Oct;15(10):1290-4
1425091
Diabetes Care. 1998 Nov;21(11):1848-55
9802732
J Am Coll Cardiol. 2008 Dec 16;52(25):2198-205
19095139
Atherosclerosis. 2002 Sep;164(1):161-6
12119205
Am J Kidney Dis. 2009 Jun;53(6):982-92
19339088
Circulation. 1997 Sep 2;96(5):1432-7
9315528